Chandan Rajgopal Soni
About Chandan Rajgopal Soni
Data last updated:
Chandan Rajgopal Soni has 17 years in corporate governance. Holds Director role. Currently with 3 companies, including Gripil Pharmaceuticals Private Limited and Satvam Pharma Private Limited. Formerly with 1 company, such as Medispin Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹34.17 Cr; the largest is Alicon Pharmaceutical Private Limited at ₹28.34 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alicon Pharmaceutical Private Limited U99999MH1995PTC086137 | Director | 16 Feb 2018 | 1995 | ₹28.34 Cr (FY 2024) | Active |
 Gripil Pharmaceuticals Private Limited U24100MH2009PTC194336 | Director | 23 Jul 2009 | 2009 | ₹5.12 Cr (FY 2024) | Active |
 Satvam Pharma Private Limited U24304MH2019PTC335058 | Director | 26 Dec 2019 | 2019 | ₹0.70 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Medispin Pharmaceutical Private Limited U24234MH2011PTC223904 | Director | 11 Apr 2016 | 2011 | ₹1.35 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandan Rajgopal Soni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandan Rajgopal Soni
Chandan Rajgopal Soni has 17 years in corporate governance. Holds Director role. Currently with 3 companies, including Gripil Pharmaceuticals Private Limited and Satvam Pharma Private Limited. Formerly with 1 company, such as Medispin Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹34.17 Cr; the largest is Alicon Pharmaceutical Private Limited at ₹28.34 Cr (FY 2024).
Chandan Rajgopal Soni is associated with 3 companies as Director, including Alicon Pharmaceutical Private Limited (₹28.34 Cr), Gripil Pharmaceuticals Private Limited (₹5.12 Cr), Satvam Pharma Private Limited (₹0.70 Cr).
Chandan Rajgopal Soni has expertise in General Business.
Chandan Rajgopal Soni has 17 years in corporate governance.
By reported revenue, the largest current company of Chandan Rajgopal Soni is Alicon Pharmaceutical Private Limited, with revenue of ₹28.34 Cr (FY 2024).
The 3 current companies of Chandan Rajgopal Soni that report revenue have a combined latest revenue of ₹34.17 Cr.
Chandan Rajgopal Soni currently holds positions at 3 companies: Alicon Pharmaceutical Private Limited (₹28.34 Cr), Gripil Pharmaceuticals Private Limited (₹5.12 Cr), Satvam Pharma Private Limited (₹0.70 Cr).